VR Collaboration System to Improve Mental Health Outcomes
Remote Cross-Platform VR Collaboration System for Mechanically Ventilated ICU Patients to Improve Mental Health Outcomes
1 other identifier
interventional
566
1 country
1
Brief Summary
Collaboration between family members and mechanically ventilated (MV) patients in the intensive care unit (ICU) is essential for improving patients' hospitalization experiences and outcomes. However, numerous hospitals have reduced the visiting time and frequency in ICUs due to the global spread of SARS-CoV-2 in recent years, aggravating mental problems and reducing the satisfaction of ICU patients and their families. Therefore, we propose an effective intervention strategy to enhance patient-family bonding and improve patient mental health and ICU experience by constructing a remote cross-platform virtual reality collaboration system (VRCS) for connecting family members at home with patients in the ICU. We aim to assess the effects of VRCS on the mental health of ICU patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2023
CompletedStudy Start
First participant enrolled
March 7, 2023
CompletedFirst Posted
Study publicly available on registry
March 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 17, 2024
CompletedMarch 17, 2023
June 1, 2022
1 year
March 6, 2023
March 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital Anxiety and Depression Scale
The HADS is designed by Zigmond and Snaith in 1983 to assess anxiety and depression symptoms in medical patients, including 14 items and every item scoring from 1 to 4. It includes two scales, one for anxiety (HADS-A) and another for depression (HADS-D). Each scale has 7 items and has a total score range from 7 to 28. The diagnostic criteria are that if the diagnosed person scores more than 11 points on any scale, it can be regarded as a confirmed case.
1 year
Secondary Outcomes (13)
Blood pressure
1 year
Heart Rate
1 year
Respiratory rate
1 year
Oxygen saturation level
1 year
Activation of cranial nerve signals
1 year
- +8 more secondary outcomes
Study Arms (2)
VR collaborative visualization group
EXPERIMENTALIn this intervention system, the stimulation materials, communication interface, collaboration tasks, and immersive 360-degree scenario will be played inside a commercially available head-mounted display on the patient side, as well as these materials will be played in the smartphone on the family members' side.
Standard ICU Care
NO INTERVENTIONPatients will be treated with standard ICU care and not receive VR stimulation.
Interventions
Patients wear virtual reality head-mounted displays while family members using smart phones to interact in a same virtual space.
Eligibility Criteria
You may qualify if:
- Mechanical ventilation time \> 24h, and is currently undergoing mechanical ventilation;
- Age ≥ 18 years old, no upper age limit;
- Language: Chinese;
- RAAS score ≥ -2 points;
- Hemodynamic stability.
You may not qualify if:
- Severe visual impairment (WHO classification: severe visual impairment) or hearing impairment (WHO classification: severe hearing loss);
- Cognitive and consciousness impairment;
- Head trauma or surgery resulting in an inability to wear HMDs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PUMC
Beijing, Beijing Municipality, 100730, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yun Long, MD
Peking Union Medical College
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2023
First Posted
March 17, 2023
Study Start
March 7, 2023
Primary Completion
March 17, 2024
Study Completion
March 17, 2024
Last Updated
March 17, 2023
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share